CCVAX | VSCIX | CCVAX / VSCIX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 20 years | 27 years | - |
Gain YTD | 11.832 | 10.899 | 109% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 5000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.82B | 149B | 2% |
Annual Yield % from dividends | 0.11 | 1.43 | 8% |
Returns for 1 year | 23.15 | 25.54 | 91% |
Returns for 3 years | 3.52 | 8.92 | 39% |
Returns for 5 years | 33.08 | 53.46 | 62% |
Returns for 10 years | 47.01 | 121.62 | 39% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FTPIX | 82.31 | -0.05 | -0.06% |
Invesco Technology R5 | |||
RAZCX | 10.83 | -0.01 | -0.09% |
Russell Inv Multi-Asset Growth Strat C | |||
DNFGX | 43.48 | -0.19 | -0.44% |
Dunham Focused Large Cap Growth N | |||
JHUKX | 31.17 | -0.17 | -0.54% |
JPMorgan Emerging Markets Equity R4 | |||
FOVIX | 32.36 | -0.40 | -1.22% |
First Trust/Confluence Small Cap Val I |